Semglee (insulin glargine-yfgn or insulin glargine) is a long-acting insulin. It's used to manage blood sugar levels in adults and children with Type 1 diabetes or Type 2 diabetes. Semglee (insulin glargine) is injected under the skin, typically once daily. Your care team will determine your dose of Semglee (insulin glargine) based on different factors, such as your diet and blood sugar levels. Semglee (insulin glargine) comes as a vial and a prefilled insulin pen. Some side effects of this medication include redness and swelling at the injection site, and upper respiratory tract infections.
Semglee (insulin glargine) is an interchangeable biosimilar alternative to Lantus (insulin glargine).
Semglee (insulin glargine) is an insulin. Insulin is a natural hormone your body makes to control blood sugar levels. It helps your body absorb and store sugar from the bloodstream after a meal. Insulin also stops your liver from making glucose (sugar). But people with diabetes can't make insulin, don't make enough insulin, or their body doesn't respond to insulin as it should.
Semglee (insulin glargine) is a long-acting, lab-made version of the insulin. It's slowly released into the body and helps your body manage blood sugar levels throughout the day. Semglee (insulin glargine) is used by people who don't make insulin or need more insulin than what their body can produce.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Type 2 diabetes (T2D)
Note: People with T1D typically experienced less side effects than people with T2D, but are at higher risk for hypoglycemia.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Tips on how to use Semglee (insulin glargine)
Tips on storing Semglee (insulin glargine)
Yes, Semglee (insulin glargine) is a long-acting insulin. You typically inject this insulin once daily. And it helps control your blood sugar levels throughout the day.
After you inject Semglee (insulin glargine), it's absorbed slowly into the body and starts to lower blood sugar levels in about 2 to 4 hours.
The "-yfgn" in Semglee (insulin glargine-yfgn) doesn't stand for anything. It isn't an acronym, or shortened form of any words. But rather, it's a four-letter suffix added so that people don't confuse Semglee (insulin glargine-yfgn) with Lantus (insulin glargine), the first insulin glargine product on the market. Semglee (insulin glargine-yfgn) is a biosimilar to Lantus (insulin glargine). Being a biosimilar means Semglee (insulin glargine) is very similar to Lantus (insulin glargine) in terms of how well it works and what side effects it might cause. The FDA requires that all biosimilars have a four-letter suffix added to minimize confusion with the original medication and with other biosimilars.
Semglee (insulin glargine) and Lantus (insulin glargine) aren't exactly the same, but they're interchangeable biosimilar medications. This means that they're very similar to each other in terms of how well they work and what side effects they might cause. In addition, it means there's data that shows people can switch between the two medications without problems. You can think of Semglee (insulin glargine) as a generic of and possible lower-cost alternative to Lantus (insulin glargine). So if a healthcare professional (HCP) prescribes Lantus (insulin glargine) for you, your pharmacist can substitute it with Semglee (insulin glargine) without contacting your HCP for approval.
No, Semglee (insulin glargine) isn't the same as Ozempic (semaglutide). While both medications are prescribed to lower blood sugar levels, they work in different ways. Semglee (insulin glargine) is a man-made version of insulin, a hormone your body naturally makes to control blood sugar levels. Semglee (insulin glargine) is prescribed for people who don't make insulin or need more insulin than what their body can produce. Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) agonist. It's a lab-made form of GLP-1, another hormone your body naturally makes. GLP-1 plays different roles in the body, such as telling the body to release insulin or slowing down how quickly food moves out of the stomach. Ask your healthcare team if you have more questions about Semglee (insulin glargine) and Ozempic (semaglutide).
Some people have reported weight gain after starting insulins, including Semglee (insulin glargine). The reason for this is because insulin tells your cells to take up sugar from the blood in order to lower blood sugar levels. The sugar in cells is then converted into fat. Over time, this can lead to weight gain. Talk with your diabetes care team if you're concerned about gaining weight while using Semglee (insulin glargine). They can recommend ways to maintain a healthy weight by planning meals with lean proteins (e.g., turkey, fish), healthy fats (e.g, avocados, nuts), and fiber (e.g., leafy greens, broccoli). They can also help you build a regular exercise routine that's suitable for you. Talk with your healthcare team if you've more questions about the risk of weight gain from Semglee (insulin glargine).
It's best to avoid drinking alcohol if you're using Semglee (insulin glargine) or any other form of insulin. Drinking alcohol raises your risk of low blood sugar levels, which is a serious side effect of insulin as well. But if you drink alcohol regularly and it's difficult for you to stop, let your diabetes care team know. They can recommend some resources to help you quit drinking or talk with you about what might be a safer amount to drink. It's important that you know how to recognize symptoms of dangerously low blood sugar levels, such as sweating, shakiness, and anxiety. Keep fast-acting sugars, such as glucose tablets, with you at all times so you can raise your blood sugar levels to a safe range.
If you just picked up Semglee (insulin glargine) pens or vials from the pharmacy and haven't started using them, you can store them in the refrigerator until the expiration date on the box, or at room temperature for 28 days. But once you've started using Semglee (insulin glargine) vials, you can store them at room temperature or in the refrigerator for up to 28 days. And if you've started using Semglee (insulin glargine) pens, they can be stored at room temperature for up to 28 days; don't refrigerate used pens again. Make sure to protect Semglee (insulin glargine) from heat and light.
Semglee (insulin glargine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Never share Semglee (insulin glargine) pens, syringes, or needles with anyone else. Doing so puts you and others at risk of getting serious infections, including human immunodeficiency virus (HIV) and hepatitis B (HBV).
Changing your insulin or insulin routine, such as where you inject Semglee (insulin glargine) or switching to a Semglee (insulin glargine) biosimilar, can affect how your body responds to insulin. This can lead to either high or low blood sugar levels. In addition, injecting Semglee (insulin glargine) repeatedly into skin areas that shows signs of lipodystrophy, such as pitting or thickened skin, can also result in high blood sugar levels.
Don't make changes to your Semglee (insulin glargine) dose or routine without first checking in with your diabetes care team. Make sure to avoid injecting into skin areas that show signs of lipodystrophy. If your care team instructs you to make any changes to your insulin routine, they'll also ask you to check your blood sugar levels more often to see how the changes affect your blood sugar levels.
Using Semglee (insulin glargine) alone or together with other medications that lower blood sugar can lead to hypoglycemia, which is dangerously low blood sugar levels. If not treated in time, it can be life-threatening.
Check your blood sugar level regularly to make sure it's within a safe range. If your diabetes care team instructs you to mix different insulins together, read the label of the insulins carefully to make sure you're using the right products. But remember, Semglee (insulin glargine) should never be mixed with other insulins in the same syringe. If you make any changes to your diet or meal patterns, other medications, or how much you exercise, let your care team know because they might need to adjust your dose of Semglee (insulin glargine).
Make sure you're familiar with symptoms of hypoglycemia, such as feeling shaky, being nervous or anxious, sweating or body chills, and excessive hunger. Keep fast-acting sugars, such as glucose tablets, with you at all times so you can treat an episode of hypoglycemia. If your blood sugar levels don't improve even after you take fast-acting sugars, get medical help right away.
Semglee (insulin glargine) can cause low potassium levels in your blood, which can be dangerous. You're at higher risk if you're already taking medications that can lower potassium levels, such as loop diuretics. Because people with low blood potassium levels typically don't experience any symptoms, your care team might order blood tests to check your potassium levels regularly. And if needed, they'll prescribe you medications to bring your potassium level within a safe range. Get medical help right away if you notice symptoms of low potassium levels such as weakness, muscle cramps or twitches, and constipation.
Taking Semglee (insulin glargine) with glitazones (also known as thiazolidinediones), like Actos (pioglitazone), can cause your body to hold onto fluid. This can be especially dangerous if you have heart failure because additional fluid can worsen your condition and cause symptoms such as difficulty breathing, swelling, and tiredness.
Make sure to tell your diabetes care team if you have heart failure or if you're taking a glitazone before starting Semglee (insulin glargine).
Rarely, Semglee (insulin glargine) can cause a serious, life-threatening reaction (e.g., anaphylaxis). If you experience swelling in your lips, face, or tongue, rash, or trouble breathing, get medical help right away.
Your diabetes care team will work with you to determine your dose of Semglee (insulin glargine). The dose of Semglee (insulin glargine) will be different for each person. It depends on different factors, such as whether you have type 1 or type 2 diabetes and how well your body responds to insulin.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Semglee (insulin glargine) will not be safe for you to take.